Trial no.:
|
PACTR202102546768103 |
Date of Approval:
|
18/02/2021 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Efficacy and Safety of Diclofenac Suppository for Post-operative Pain Relief After Diagnostic Hystero-laparoscopy and Dye Test: A Double-blind Placebo Controlled Randomised Study |
Official scientific title |
Efficacy and Safety of Diclofenac Suppository for Post-operative Pain Relief After Diagnostic Hystero-laparoscopy and Dye Test: A Double-blind Placebo Controlled Randomised Study |
Brief summary describing the background
and objectives of the trial
|
Diagnostic hystero-laparoscopy and dye test (dHLD) has emerged as the essential tool for the evaluation of female infertility and is the gold standard investigation for tubal patency. Although DHL is performed under general anaesthesia, the pain following the procedures can be enormous. Pain in the postoperative period can result in delayed discharge or prolonged hospital stay following endoscopic procedures with attendant cost implications. This study is aimed at evaluating the efficacy and safety of diclofenac suppository for relieving postoperative pain after diagnostic hystero-laparoscopy and dye test |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
Fertility-female |
Purpose of the trial |
Prevention |
Anticipated trial start date |
03/12/2020 |
Actual trial start date |
03/12/2020 |
Anticipated date of last follow up |
30/04/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
108 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|